Haoxi Health Technology Limited Closes Private Placement Offering

Haoxi Health Technology Limited has successfully closed its private placement offering, issuing 5,217,391 Class A ordinary shares at a purchase price of $0.23 per share. The offering, which was conducted under Regulation S of the Securities Act of 1933, resulted in gross proceeds of $1.2 million before customary expenses. The net proceeds will be used for working capital and general corporate purposes. The closing occurred on October 22, 2025, after all conditions of the securities purchase agreement were satisfied. Following the offering, the company has a total of 7,503,028 Class A ordinary shares and 690,800 Class B ordinary shares issued and outstanding.